18 June 2020

On 1 April, two new professors were added to the Cardiology department at Radboudumc. Jan Hein Cornel has been named by special appointment as professor of Inflammation in Atherosclerotic Cardiovascular Disease, and Robert-Jan van Geuns has been appointed as the new professor of Interventional Cardiology. The newly appointed professors will give a new impulse to the research at the Department of Cardiology and the Cardiovascular Centre of Radboudumc into the causes and treatments of arteriosclerosis of the heart.

Jan Hein Cornel specialises in mechanisms of action and new clinical anti-inflammatory treatment options for both chronic and acute heart problems due to arteriosclerosis. At Radboudumc, Cornel focuses on inflammation of the vessel wall; based on this research topic, he will enter into a strategic collaboration involving Radboudumc, WCN (Werkgroep Cardiologische centra Nederland) and the Noordwest Hospital Group in Alkmaar and Den Helder. Central to this research is the progression of inflammation of the vessel wall and the consequences for its treatment. This special appointment was made possible by the three partners: Radboudumc, WCN and Noordwest.
 
Jan Hein Cornel (Harlingen, 1960) studied medicine at the University of Groningen, specialised in cardiology and worked at the Thorax Center, Dijkzigt hospital (now Erasmus MC) in Rotterdam. He received his doctorate in 1996 for research into myocardial viability in ischemic syndromes. Cornel has worked as a cardiologist at the Noordwest Hospital Group in Alkmaar and Den Helder since 1995. He was also a cardiology instructor at Noordwest.
 
Cornel’s expertise as a clinical trialist in large international studies is a valuable addition to the existing research lines at Radboudumc. In collaboration with WCN and Noordwest, Cornel is translating academic findings, through clinical trials, into clinical practice.
 
Robert-Jan van Geuns specialises in complex PCI (percutaneous coronary interventions). Van Geuns is an expert in complex PCI such as treatments for situations in which the veins in the heart are completely blocked (CTO – chronic total occlusion) or PCI must be used in acute situations where extracorporeal membrane oxygenation (ECMO) is required to support heart failure.

As professor of Interventional Cardiology, he will focus on the specification of the multidisciplinary assessment (together with the cardiac surgeons) and combined research looking at both the best indication methodology and a combination of early and late pharmacotherapy, in relation to the materials used during PCI. Important themes in this research will be the diagnosis and treatment of early arteriosclerosis and the treatment of acute and/or complex myocardial infarction.

Robert-Jan van Geuns (Son & Breugel, 1966) studied medicine at the University of Leiden, specialised in cardiology and interventional cardiology and obtained his doctorate in 2000 at Erasmus University on research into non-invasive coronary imaging with MRI and electron beam computed tomography. After his PhD, he continued to work as a cardiologist at Erasmus MC, where he was coordinator of the Interventional Cardiology department from 2012 to 2014. He was appointed in 2014 as professor by special appointment in Interventional Cardiology at Erasmus MC.

Since moving to Radboudumc, his primary remit has been to strengthen interventional cardiology research. He has since received grants, started building a new research group and held seminars on invasive imaging and physiology of the heart for an international audience.

Young researchers

These two professorial appointments will give young researchers, medical students and specialists in training an excellent opportunity to become acquainted with and contribute to this societally and scientifically important research.
 
 

Related news items


AI helps the defibrillator think

4 October 2021

In the future, the AED and the defibrillator will be able to do more than they do today. Now the devices can only give patients who need to be resuscitated a shock, but in time it will be possible, with the help of artificial intelligence, to say more about the condition of the patient.

read more

Experts call for urgent action to reduce global burden of cardiovascular disease in women by 2030

17 May 2021

There is an urgent need to address this, states the international Lancet 'Women and Cardiovascular Disease' Commission

read more

Water as a new tool for cardiac screening for chest pain

2 March 2021

Patients with chest pain not caused by a narrowing of the coronary arteries often do not know the cause of their symptoms. Scientists at the Radboudumc have successfully used a new technique to investigate other causes in the coronary arteries of the heart.

read more

Pregnancy complications and early menopause affect cardiovascular disease in women

9 February 2021

A number of specific conditions in women are important in their risk of cardiovascular disease. These include high blood pressure during pregnancy, gestational diabetes and early menopause.

read more

Centuries-old medicine reduces the risk of new cardiovascular disease in heart patients

17 September 2020

Colchicine, an anti-inflammatory drug that has been used for gout for centuries, has been shown to prevent cardiovascular disease in patients who have had a heart attack or are suffering from narrowed coronary arteries. Results of the study are published in the New England Journal of Medicine.

read more

Cardiac function in relation to myocardial injury in hospitalised patients with COVID-19

16 July 2020

In Netherlands Heart Journal RIHS researcher Frederik van den Heuvel described that in hospitalized COVID-19 patients, COVID-19 predominantly affects the respiratory system, while cardiac dysfunction occurs less often.

read more